by SEO Luxeveda | May 13, 2026 | Insights, Blogs
“The right CDMO is not the one with the biggest plant or the lowest price. It’s the one with the judgment, the systems, and the incentives to protect your molecule when complexity, scale, and scrutiny converge.” Alessio Piccoli, Chief Commercial Officer at PI Health...
by SEO Luxeveda | Apr 16, 2026 | Insights, Blogs
We are proud to announce that PI Health Sciences has achieved ISO/IEC 27001:2022 certification across our Mumbai Head Office, Jaipur, and Hyderabad sites. This milestone reinforces our unwavering commitment to protecting sensitive data—whether it belongs to our...
by SEO Luxeveda | Mar 2, 2026 | Immunoenicity, Discovery Biology, Discovery Solutions, Insights, Blogs
As the immuno-oncology landscape continues to expand, the demand for robust, reproducible, and mechanistically informative in vitro assay systems has grown in parallel. Mixed Lymphocyte Reaction assays have emerged as one of the most relevant tools for evaluating the...
by SEO Luxeveda | Feb 27, 2026 | Discovery Biology, Peptides, Discovery Solutions, Insights, Blogs
In Drug discovery and development, the precise quantification of biomolecular interactions, including binding kinetics, affinity constants, and concentration measurements-constitutes a foundational requirement for candidate characterization and lead optimization....
by abishek | Sep 2, 2025 | Insights, Discovery Solutions, Blogs
For decades, drug discovery has been notorious for its staggering costs, painfully long timelines, and high attrition rates. On average, developing a new medicine takes 10–15 years and costs upwards of $2 billion. Yet, in the past five years, artificial intelligence...
by abishek | May 15, 2025 | Insights, Blogs, Media, Awards
At PI Health Sciences, excellence isn’t just a goal—it’s a commitment. We’re proud to share that PI Health Sciences Hyderabad site is now officially certified for both ISO 14001:2015 (Environmental Management Systems) and ISO 45001:2018 (Occupational...
